Hardarson, Emil
Islind, Anna Sigridur
Arnardottir, Erna Sif
Óskarsdóttir, María
Funding for this research was provided by:
Horizon 2020 Framework Programme (965417)
Icelandic Centre for Research (90458)
Article History
Accepted: 6 April 2023
First Online: 30 June 2023
Declarations
:
: Dr. Arnardottir discloses lecture fees from Nox Medical, Philips, ResMed, Jazz Pharmaceuticals, Linde Healthcare, Alcoa - Fjardaral, Visitor (Novo Nordisk) and Wink Sleep. She is also a member of the Philips Sleep Medicine & Innovation Medical Advisory Board. The other authors declare that they have no conflict of interest.
: This research involved data from human participants. The data is publically available [CitationRef removed, CitationRef removed]